IPhone 16 official first price reduction across all models: up to 1600 yuan cheaper
阿豆学长长ov
发表于 2024-10-21 18:31:49
174
0
0
On October 21st, multiple models under the # iPhone16 official banner were released and went viral on the hot search list.
At the 2024 Double 11 E-commerce Festival, Apple's iPhone 16 series, which has only been released for one month, saw a price reduction across all models, marking the first official channel price reduction since the release of the new phone.
According to Caixin News Agency, the official flagship store of Apple Store announced a Tmall Double 11 promotion, which will be available in stock at 8 pm on October 21st, with the iPhone 16 series offering a maximum discount of 1600 yuan.
According to the official flagship store strategy, iPhone, iPad, Apple Watch, AirPods and other series of products enjoy varying degrees of discount. Among them, the iPhone 16 series products can use Tmall to issue a 500 yuan surprise coupon, with a maximum subsidy of 1100 yuan for trade in, and enjoy up to 12 interest free periods.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- AstraZeneca CEO responds for the first time to Chinese executive detention: Wang Lei is discussing with lawyer
- Why did the stock price of Bilibili, which achieved profitability for the first time in the quarter, fall by more than 13%?
- Depth | From relying on games to relying on games again, Bilibili disguises itself as a community and makes its first "atypical" profit
- JD Seven Fresh: Products with breakthrough prices are 10% cheaper than other instant retail platforms
- Ideal Automobile implements a limited time zero interest policy for all models for the first time
- Car Technology: Achieved profitability for the first time in the third quarter, with both the number of new energy vehicle insurance policies and premiums doubling year-on-year
- Morningstar Corporation: Still optimistic about the list of three cheap stocks in 2025
- BeiGene ADC's new cancer drug BG-C137 has been clinically approved for the first time in China
- Blue Origin New Glenn rocket launches critical tests before first launch
- Beike acquires land for the first time in Shanghai to build a building. This year, the final battle of homestead transactions has ignited new highlights